Literature DB >> 10630326

Antithrombin III concentrate in the acute phase of thermal injury.

A Kowal-Vern1, V McGill, J M Walenga, R L Gamelli.   

Abstract

BACKGROUND: Thermal injury disrupts homeostasis by inducing subclinical disseminated intravascular coagulation, fibrinolysis. and an acquired deficiency of Antithrombin III (ATIII), a natural anticoagulant. As a result, thermally injured patients have a high incidence of hypercoagulability and thrombosis.
OBJECTIVE: ATIII (Human) concentrate was given to a thermally injured patient to evaluate safety, and dosage requirements in this setting.
DESIGN: The patient was a 40 yr old male with a 68% total burn surface area, right femoral comminuted fracture, and C5-C6 subluxation sustained in a vehicular crash. He received nine infusions of AT III (H) concentrate (100-50 u/kg) within the first four days of injury. RESULT: The ATIII plasma level increased from 45% on admission (normal = 100+/-20%) to 120+/-25% in the next four days. During the 64 day hospitalization, there were 11 grafting procedures with an estimated blood loss (EBL)/procedure: 1140 cc; and EBL/grafted surface area ratio: 0.6 cc cm2. The average time to healing of the meshed autograft was 6.4 days.
CONCLUSION: ATIII (H) concentrate can be safely utilized in the acute phase of thermal injury: no excessive bleeding or prolongation of wound healing was documented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10630326     DOI: 10.1016/s0305-4179(99)00099-6

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  6 in total

1.  Antithrombin III Prevents Early Bacterial Translocation in Burn Injury.

Authors:  O Herek; M Yılmaz; I Kaleli; N Cevahir; N Demirkan
Journal:  Ann Burns Fire Disasters       Date:  2006-12-31

2.  Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice.

Authors:  Erin B Dickerson; Erik C Dreaden; Xiaohua Huang; Ivan H El-Sayed; Hunghao Chu; Sujatha Pushpanketh; John F McDonald; Mostafa A El-Sayed
Journal:  Cancer Lett       Date:  2008-06-09       Impact factor: 8.679

3.  Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study.

Authors:  Takashi Tagami; Hiroki Matsui; Yuuta Moroe; Reo Fukuda; Ami Shibata; Chie Tanaka; Kyoko Unemoto; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Ann Intensive Care       Date:  2017-02-20       Impact factor: 6.925

Review 4.  Pathophysiology, research challenges, and clinical management of smoke inhalation injury.

Authors:  Perenlei Enkhbaatar; Basil A Pruitt; Oscar Suman; Ronald Mlcak; Steven E Wolf; Hiroyuki Sakurai; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

Review 5.  Burn-Induced Coagulopathies: a Comprehensive Review.

Authors:  Robert L Ball; John W Keyloun; Kathleen Brummel-Ziedins; Thomas Orfeo; Tina L Palmieri; Laura S Johnson; Lauren T Moffatt; Anthony E Pusateri; Jeffrey W Shupp
Journal:  Shock       Date:  2020-08       Impact factor: 3.533

6.  Topics in burn critical care-chest pain.

Authors:  Neeraj M Shah; Justin Klaff; Stephen M Milner; Leigh A Price; Kevin B Gerold
Journal:  Eplasty       Date:  2013-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.